Josefa Salgado Garrido-rekin lankidetzan egindako argitalpenak (12)

2015

  1. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer

    Mitochondrial DNA, Vol. 26, Núm. 2, pp. 227-231

2013

  1. KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients

    Oncology Letters, Vol. 6, Núm. 5, pp. 1343-1345

2011

  1. A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation

    Oncology Letters, Vol. 2, Núm. 5, pp. 807-809

2010

  1. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family

    Breast Cancer Research and Treatment, Vol. 121, Núm. 1, pp. 219-220

  2. Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 291-293

2009

  1. A novel BRCA1 mutation in a Spanish patient with ovarian cancer

    Breast Cancer Research and Treatment, Vol. 113, Núm. 1, pp. 71-73

2008

  1. A characterization of genetic haplotypes in BRCA1 identifies linkage disequilibrium with a novel polymorphism in intron 7

    Gene Therapy and Molecular Biology, Vol. 12, Núm. 2, pp. 175-180

  2. Review: Mitochondrial defects in breast cancer

    Clinical Medicine: Oncology, Vol. 2, pp. 199-207

2007

  1. GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment

    Current Drug Metabolism, Vol. 8, Núm. 5, pp. 481-486

  2. Oncogenes y genes supresores en cáncer

    Arán

  3. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer

    Oncology Reports, Vol. 17, Núm. 2, pp. 325-328

2005

  1. Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population

    Oncology Reports, Vol. 14, Núm. 1, pp. 85-88